Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Movement disorders
How do you decide between Vyalev and Onapgo for patients who would benefit from continuous dopaminergic stimulation?
Related previous discussion on
theMednet on Vyalev
.
Answer from: at Community Practice
Either is fine.
Sign In
or
Register
to read more
30087
Related Questions
Do you prescribe respiratory muscle training (RMT) devices to patients with dysphagia?
How do you manage levodopa in a patient with Parkinson's and RLS with augmentation?
How do you decide between the different oral longer acting levodopa medications?
Which essential tremor phenotypes benefit most from wearable peripheral nerve stimulator devices?
How do you counsel patients on the cognitive effects of DBS for Parkinson's disease?
When do you find ultrasound guidance to be most helpful for botulinum toxin injection?
Do you consider DBS for Essential Tremor in patients who already underwent Focused Ultrasound Thalamotomy?
How can I incorporate neuromuscular ultrasound into my practice with limited prior experience?
Which imaging features do you use when considering Normal Pressure Hydrocephalus to decide whether to proceed with large-volume LP or lumbar drain trial?
Do you ever delay starting levodopa in patients with Parkinson's disease?